That's exactly right, however in this case Regen has been working with the FDA on the experimental study and the FDA has already approved the clinical protocol and manufacturing of Hemaxellerate. They just had to submit the safety data in which there were no adverse effects. IMO it will be a quick process.
News 
Market Data 
Discover 
